Genedrive Diagnostics Ltd
UK-based developer and commercialiser of a point-of-care molecular diagnostic thermocycler platform and rapid pharmacogenetic assays. The company focuses on rapid genotyping to inform clinical treatment decisions in time-critical settings (notably neonatal intensive care and acute stroke care) and has conducted clinical pilots and NHS implementations for its assays.
Industries
Nr. of Employees
small (1-50)
Genedrive Diagnostics Ltd
Products
Point-of-care molecular diagnostic thermocycler platform
A compact point-of-care thermocycler platform designed to run single-use cartridge assays for rapid genetic variant detection at or near the bedside.
Rapid pharmacogenetic cartridge assays (antiplatelet and antibiotic risk)
Single-use cartridge assays for rapid detection of specific genetic variants that inform antiplatelet therapy selection and antibiotic-induced hearing-loss risk in neonates.
Point-of-care molecular diagnostic thermocycler platform
A compact point-of-care thermocycler platform designed to run single-use cartridge assays for rapid genetic variant detection at or near the bedside.
Rapid pharmacogenetic cartridge assays (antiplatelet and antibiotic risk)
Single-use cartridge assays for rapid detection of specific genetic variants that inform antiplatelet therapy selection and antibiotic-induced hearing-loss risk in neonates.
Services
E-learning modules, training videos, user manuals and distributor product guides for deployment and use of near-patient diagnostic devices.
Provision of product demonstrations and engagement to support pilot deployment and local pathway integration.
E-learning modules, training videos, user manuals and distributor product guides for deployment and use of near-patient diagnostic devices.
Provision of product demonstrations and engagement to support pilot deployment and local pathway integration.
Expertise Areas
- Pharmacogenetic testing
- Point-of-care molecular diagnostics
- Rapid genotyping for clinical decision support
- Assay and reagent development
Key Technologies
- PCR / real-time DNA amplification
- Point-of-care thermocycler platform
- SNP genotyping assays
- Single-use disposable cartridge assays
News & Updates
Event listing for an industry conference.
Announcement of a pilot programme implementing rapid CYP2C19 genotyping in rural Scottish hospitals to assess impact on stroke care.
Summary of pilot programme results showing feasibility and clinical impact of near-patient CYP2C19 testing in NHS stroke services.
Notice of publication of an NHS implementation guide supporting CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or TIA.
Announcement of phased national rollout of a rapid MT-RNR1 genotyping test across NHS Scotland neonatal units.
Notification that the company obtained UKCA marking for its CYP2C19 genotyping test.
Event listing for an industry conference.
Announcement of a pilot programme implementing rapid CYP2C19 genotyping in rural Scottish hospitals to assess impact on stroke care.
Summary of pilot programme results showing feasibility and clinical impact of near-patient CYP2C19 testing in NHS stroke services.
Notice of publication of an NHS implementation guide supporting CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or TIA.
Announcement of phased national rollout of a rapid MT-RNR1 genotyping test across NHS Scotland neonatal units.
Notification that the company obtained UKCA marking for its CYP2C19 genotyping test.